American Journal of Obstetrics & Gynecology
Volume 191, Issue 2 , Pages 398-407, August 2004

Prescription drug use in pregnancy☆

Meyers Primary Care Institute-Fallon Healthcare System and University of Massachusetts Medical School, Worcester, Massa; Center for Health Studies, Group Health Cooperative, Seattle, Washb; Channing Laboratory, Brigham and Women's Hospital, Boston, Massc; Department of Epidemiology, Harvard School of Public Health, Boston, Massd; Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, Masse; HealthPartners Research Foundation, Minneapolis, Minnf; Kaiser Permanente Colorado, Denver, Colog; Kaiser Permanente Georgia, Atlanta, Gah; Kaiser Permanente Northwest, Portland, Orei; Henry Ford Health Systems, Detroit, Michj; The HMO Research Network Center for Education and Research in Therapeuticsk USA

Received 29 October 2003; received in revised form 1 April 2004; accepted 21 April 2004.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Supported by grant HS10391 from the Agency for Healthcare Research and Quality to The HMO Research Network Center for Education and Research in Therapeutics (CERT).

PII: S0002-9378(04)00420-X

doi:10.1016/j.ajog.2004.04.025

American Journal of Obstetrics & Gynecology
Volume 191, Issue 2 , Pages 398-407, August 2004

Article Tools